1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Service 41
3.1 Market Overview by Service 41
3.2 Genotyping 43
3.3 SNP Identification 44
3.4 Diagnostics 45
3.5 Other Services 47
4 Segmentation of Asia Pacific Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.3 Microarray 51
4.4 Sequencing 52
4.5 Electrophoresis 53
4.6 Mass Spectrometry 54
4.7 Other Technologies 55
5 Segmentation of Asia Pacific Market by Application 56
5.1 Market Overview by Application 56
5.2 Oncology 58
5.3 Infectious Diseases 59
5.4 Neurology/Psychiatry 60
5.5 Cardiovascular 62
5.6 Pain Management 63
5.7 Other Applications 64
6 Segmentation of Asia Pacific Market by End User 65
6.1 Market Overview by End User 65
6.2 Hospitals and Clinics 67
6.3 Pharmaceutical Companies 68
6.4 Research Institutes 69
7 Asia-Pacific Market 2019-2030 by Country 70
7.1 Overview of Asia-Pacific Market 70
7.2 Japan 73
7.3 China 76
7.4 Australia 78
7.5 India 80
7.6 South Korea 82
7.7 Rest of APAC Region 84
8 Competitive Landscape 86
8.1 Overview of Key Vendors 86
8.2 New Product Launch, Partnership, Investment, and M&A 90
8.3 Company Profiles 91
23andMe, Inc. 91
Abbott Laboratories 93
Admera Health, LLC 94
Agena Biosciences, Inc. 95
Astra Zeneca PLC 96
Bayer AG 97
Becton, Dickinson and Company 98
Cancer Genetics, Inc. 99
Dynamic DNA Laboratories 100
Empire Genomics LLC 101
F. Hoffmann-La Roche Ltd 102
geneOmbio Technologies Pvt Ltd. 103
Genomic Health, Inc. 104
Illumina, Inc. 105
Laboratory Corporation of America Holdings 106
Myriad Genetics Inc. 107
Oneome LLC 108
Opko Health, Inc. 109
Pathway Genomics Corporation 110
QIAGEN N.V. 111
Quest Diagnostics Incorporated 112
Teva Pharmaceuticals Industries Ltd. 113
Thermo Fisher Scientific Inc. 114
Transgenomic, Inc. 115
9 Investing in Asia Pacific Market: Risk Assessment and Management 116
9.1 Risk Evaluation of Asia Pacific Market 116
9.2 Critical Success Factors (CSFs) 119
Related Reports and Products 122